Based on new data, institutions offering gastric bypass surgeries, Allergan Inc.’s minimally invasive LapBands, and other surgeries for weight loss are now recasting them as treatments for Type 2 diabetes. This is a dramatic change in perspective within the drug-oriented diabetology world.
Studies of the surgical treatment of obesity and its beneficial effect on patients with Type 2 diabetes go back to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?